119 related articles for article (PubMed ID: 38140710)
21. Neoantigen prediction in human breast cancer using RNA sequencing data.
Hashimoto S; Noguchi E; Bando H; Miyadera H; Morii W; Nakamura T; Hara H
Cancer Sci; 2021 Jan; 112(1):465-475. PubMed ID: 33155341
[TBL] [Abstract][Full Text] [Related]
22. The role of neoantigen in immune checkpoint blockade therapy.
Yi M; Qin S; Zhao W; Yu S; Chu Q; Wu K
Exp Hematol Oncol; 2018; 7():28. PubMed ID: 30473928
[TBL] [Abstract][Full Text] [Related]
23. Driving neoantigen-based cancer vaccines for personalized immunotherapy into clinic: A burdensome journey to promising land.
Yu G; He X; Li X; Wu Y
Biomed Pharmacother; 2022 Sep; 153():113464. PubMed ID: 36076493
[TBL] [Abstract][Full Text] [Related]
24. Neoantigen Vaccines; Clinical Trials, Classes, Indications, Adjuvants and Combinatorial Treatments.
Niemi JVL; Sokolov AV; Schiöth HB
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291947
[TBL] [Abstract][Full Text] [Related]
25. TSNAdb v2.0: The Updated Version of Tumor-specific Neoantigen Database.
Wu J; Chen W; Zhou Y; Chi Y; Hua X; Wu J; Gu X; Chen S; Zhou Z
Genomics Proteomics Bioinformatics; 2023 Apr; 21(2):259-266. PubMed ID: 36209954
[TBL] [Abstract][Full Text] [Related]
26. Accounting for proximal variants improves neoantigen prediction.
Hundal J; Kiwala S; Feng YY; Liu CJ; Govindan R; Chapman WC; Uppaluri R; Swamidass SJ; Griffith OL; Mardis ER; Griffith M
Nat Genet; 2019 Jan; 51(1):175-179. PubMed ID: 30510237
[TBL] [Abstract][Full Text] [Related]
27. Transcriptomic profiles of neoantigen-reactive T cells in human gastrointestinal cancers.
Zheng C; Fass JN; Shih YP; Gunderson AJ; Sanjuan Silva N; Huang H; Bernard BM; Rajamanickam V; Slagel J; Bifulco CB; Piening B; Newell PHA; Hansen PD; Tran E
Cancer Cell; 2022 Apr; 40(4):410-423.e7. PubMed ID: 35413272
[TBL] [Abstract][Full Text] [Related]
28. Research progress of neoantigen-based dendritic cell vaccines in pancreatic cancer.
Zhang X; Xu Z; Dai X; Zhang X; Wang X
Front Immunol; 2023; 14():1104860. PubMed ID: 36761724
[TBL] [Abstract][Full Text] [Related]
29. Impact of Neoantigen Expression and T-Cell Activation on Breast Cancer Survival.
Li W; Amei A; Bui F; Norouzifar S; Lu L; Wang Z
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34207556
[TBL] [Abstract][Full Text] [Related]
30. CpG-ODN Facilitates Effective Intratracheal Immunization and Recall of Memory against Neoantigen-Expressing Alveolar Cells.
Riehn M; Cebula M; Hauser H; Wirth D
Front Immunol; 2017; 8():1201. PubMed ID: 29038654
[TBL] [Abstract][Full Text] [Related]
31. Predicted neoantigen load in non-hypermutated endometrial cancers: Correlation with outcome and tumor-specific genomic alterations.
Shukla SA; Howitt BE; Wu CJ; Konstantinopoulos PA
Gynecol Oncol Rep; 2017 Feb; 19():42-45. PubMed ID: 28070553
[TBL] [Abstract][Full Text] [Related]
32. Neoantigen vaccine and neoantigen-specific cell adoptive transfer therapy in solid tumors: Challenges and future directions.
Shen Y; Yu L; Xu X; Yu S; Yu Z
Cancer Innov; 2022 Aug; 1(2):168-182. PubMed ID: 38090649
[TBL] [Abstract][Full Text] [Related]
33. Challenges targeting cancer neoantigens in 2021: a systematic literature review.
Chen I; Chen MY; Goedegebuure SP; Gillanders WE
Expert Rev Vaccines; 2021 Jul; 20(7):827-837. PubMed ID: 34047245
[No Abstract] [Full Text] [Related]
34. Heterogeneity of neoantigen landscape between primary lesions and their matched metastases in lung cancer.
Jiang T; Cheng R; Pan Y; Zhang H; He Y; Su C; Ren S; Zhou C
Transl Lung Cancer Res; 2020 Apr; 9(2):246-256. PubMed ID: 32420064
[TBL] [Abstract][Full Text] [Related]
35. Computational prediction of MHC anchor locations guides neoantigen identification and prioritization.
Xia H; McMichael J; Becker-Hapak M; Onyeador OC; Buchli R; McClain E; Pence P; Supabphol S; Richters MM; Basu A; Ramirez CA; Puig-Saus C; Cotto KC; Freshour SL; Hundal J; Kiwala S; Goedegebuure SP; Johanns TM; Dunn GP; Ribas A; Miller CA; Gillanders WE; Fehniger TA; Griffith OL; Griffith M
Sci Immunol; 2023 Apr; 8(82):eabg2200. PubMed ID: 37027480
[TBL] [Abstract][Full Text] [Related]
36. A novel neoantigen discovery approach based on chromatin high order conformation.
Shi Y; Zhang M; Meng L; Su X; Shang X; Guo Z; Li Q; Lin M; Zou X; Luo Q; Yu Y; Wu Y; Da L; Cai TW; He G; Han ZG
BMC Med Genomics; 2020 Aug; 13(Suppl 6):62. PubMed ID: 32854726
[TBL] [Abstract][Full Text] [Related]
37. DeepAntigen: a novel method for neoantigen prioritization via 3D genome and deep sparse learning.
Shi Y; Guo Z; Su X; Meng L; Zhang M; Sun J; Wu C; Zheng M; Shang X; Zou X; Cheng W; Yu Y; Cai Y; Zhang C; Cai W; Da LT; He G; Han ZG
Bioinformatics; 2020 Dec; 36(19):4894-4901. PubMed ID: 32592462
[TBL] [Abstract][Full Text] [Related]
38. Identification of a neoantigen epitope in a melanoma patient with good response to anti-PD-1 antibody therapy.
Nonomura C; Otsuka M; Kondou R; Iizuka A; Miyata H; Ashizawa T; Sakura N; Yoshikawa S; Kiyohara Y; Ohshima K; Urakami K; Nagashima T; Ohnami S; Kusuhara M; Mitsuya K; Hayashi N; Nakasu Y; Mochizuki T; Yamaguchi K; Akiyama Y
Immunol Lett; 2019 Apr; 208():52-59. PubMed ID: 30880120
[TBL] [Abstract][Full Text] [Related]
39. Neoantigen vaccine platforms in clinical development: understanding the future of personalized immunotherapy.
Supabphol S; Li L; Goedegebuure SP; Gillanders WE
Expert Opin Investig Drugs; 2021 May; 30(5):529-541. PubMed ID: 33641576
[TBL] [Abstract][Full Text] [Related]
40. A Potent Micron Neoantigen Tumor Vaccine GP-Neoantigen Induces Robust Antitumor Activity in Multiple Tumor Models.
Jing Z; Wang S; Xu K; Tang Q; Li W; Zheng W; Shi H; Su K; Liu Y; Hong Z
Adv Sci (Weinh); 2022 Aug; 9(24):e2201496. PubMed ID: 35712770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
